FLT1 and Duchenne muscular dystrophy: To evaluate the potential of Flt-1 antagonism as a therapeutic strategy in DMD, we used phage display techniques to develop a monoclonal antibody (mAb) directed against Flt-1 and engineered it to enhance its affinity, specificity, and potency.